分子间与甘氨胆酸钠的特异性相互作用产生了共晶体系,使砖粉分子神经肽 Y5 受体拮抗剂显示出更高的物理稳定性和水溶性。

IF 4.4 2区 医学 Q1 PHARMACOLOGY & PHARMACY
{"title":"分子间与甘氨胆酸钠的特异性相互作用产生了共晶体系,使砖粉分子神经肽 Y5 受体拮抗剂显示出更高的物理稳定性和水溶性。","authors":"","doi":"10.1016/j.ejpb.2024.114395","DOIUrl":null,"url":null,"abstract":"<div><p>Drugs with poor water and lipid solubility are termed “brick dust.” We previously successfully developed a co-amorphous system of a novel neuropeptide Y<sub>5</sub> receptor antagonist (AntiY<sub>5</sub>R), a brick dust molecule, using sodium taurocholate (NaTC) as a co-former. However, the maximum improvement in AntiY<sub>5</sub>R dissolution by the co-amorphous system was only approximately 10 times greater than that of the crystals. Therefore, in the current study, other bile salts, including sodium cholate (NaC), sodium chenodeoxycholate (NaCC), and sodium glycocholate (NaGC), were examined as co-formers to further improve AntiY<sub>5</sub>R dissolution. NaC, NaCC, and NaGC have glass transition temperatures above 150°C. All three co-amorphous systems prepared successfully retained the amorphous form of AntiY<sub>5</sub>R for 3 months at 40°C, but the co-amorphous system with NaGC (AntiY<sub>5</sub>R-NaGC; 1:9 molar ratio) provided the highest improvement in AntiY<sub>5</sub>R dissolution, which was approximately 50 times greater than that of the crystals. Possible intermolecular interactions via the glycine moiety of NaGC more than the other bile salts would contribute to the highest dissolution enhancement with AntiY<sub>5</sub>R-NaGC. Thus, NaGC would be a promising co-former for formulating stable co-amorphous systems to enhance the dissolution behavior of brick dust molecules.</p></div>","PeriodicalId":12024,"journal":{"name":"European Journal of Pharmaceutics and Biopharmaceutics","volume":null,"pages":null},"PeriodicalIF":4.4000,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Specific intermolecular interaction with sodium glycocholate generates the co-amorphous system showing higher physical stability and aqueous solubility of Y5 receptor antagonist of neuropeptide Y, a brick dust molecule\",\"authors\":\"\",\"doi\":\"10.1016/j.ejpb.2024.114395\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Drugs with poor water and lipid solubility are termed “brick dust.” We previously successfully developed a co-amorphous system of a novel neuropeptide Y<sub>5</sub> receptor antagonist (AntiY<sub>5</sub>R), a brick dust molecule, using sodium taurocholate (NaTC) as a co-former. However, the maximum improvement in AntiY<sub>5</sub>R dissolution by the co-amorphous system was only approximately 10 times greater than that of the crystals. Therefore, in the current study, other bile salts, including sodium cholate (NaC), sodium chenodeoxycholate (NaCC), and sodium glycocholate (NaGC), were examined as co-formers to further improve AntiY<sub>5</sub>R dissolution. NaC, NaCC, and NaGC have glass transition temperatures above 150°C. All three co-amorphous systems prepared successfully retained the amorphous form of AntiY<sub>5</sub>R for 3 months at 40°C, but the co-amorphous system with NaGC (AntiY<sub>5</sub>R-NaGC; 1:9 molar ratio) provided the highest improvement in AntiY<sub>5</sub>R dissolution, which was approximately 50 times greater than that of the crystals. Possible intermolecular interactions via the glycine moiety of NaGC more than the other bile salts would contribute to the highest dissolution enhancement with AntiY<sub>5</sub>R-NaGC. Thus, NaGC would be a promising co-former for formulating stable co-amorphous systems to enhance the dissolution behavior of brick dust molecules.</p></div>\",\"PeriodicalId\":12024,\"journal\":{\"name\":\"European Journal of Pharmaceutics and Biopharmaceutics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2024-07-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Pharmaceutics and Biopharmaceutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0939641124002212\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmaceutics and Biopharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0939641124002212","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

水溶性和脂溶性较差的药物被称为 "砖粉"。此前,我们使用牛磺胆酸钠(NaTC)作为共形剂,成功开发了一种新型神经肽 Y5 受体拮抗剂(AntiY5R)的共形体系,这是一种砖粉分子。然而,共晶系统对 AntiY5R 溶解性的最大改善仅为晶体的约 10 倍。因此,在本研究中,研究人员研究了其他胆盐,包括胆酸钠(NaC)、酚脱氧胆酸钠(NaCC)和甘胆酸钠(NaGC),将其作为共形剂,以进一步提高 AntiY5R 的溶解度。NaC、NaCC 和 NaGC 的玻璃化转变温度均高于 150°C。制备的三种共晶体系都能在 40 ℃ 下成功地将 AntiY5R 的无定形形式保留 3 个月,但与 NaGC(AntiY5R-NaGC;1:9 M 比)的共晶体系对 AntiY5R 的溶解性改善最大,约为晶体的 50 倍。与其他胆盐相比,通过 NaGC 的甘氨酸分子可能产生更多的分子间相互作用,从而使 AntiY5R-NaGC 的溶解度得到最大提高。因此,NaGC 是一种很有前途的共形剂,可用于配制稳定的共晶体系,以增强砖粉分子的溶解性能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Specific intermolecular interaction with sodium glycocholate generates the co-amorphous system showing higher physical stability and aqueous solubility of Y5 receptor antagonist of neuropeptide Y, a brick dust molecule

Specific intermolecular interaction with sodium glycocholate generates the co-amorphous system showing higher physical stability and aqueous solubility of Y5 receptor antagonist of neuropeptide Y, a brick dust molecule

Drugs with poor water and lipid solubility are termed “brick dust.” We previously successfully developed a co-amorphous system of a novel neuropeptide Y5 receptor antagonist (AntiY5R), a brick dust molecule, using sodium taurocholate (NaTC) as a co-former. However, the maximum improvement in AntiY5R dissolution by the co-amorphous system was only approximately 10 times greater than that of the crystals. Therefore, in the current study, other bile salts, including sodium cholate (NaC), sodium chenodeoxycholate (NaCC), and sodium glycocholate (NaGC), were examined as co-formers to further improve AntiY5R dissolution. NaC, NaCC, and NaGC have glass transition temperatures above 150°C. All three co-amorphous systems prepared successfully retained the amorphous form of AntiY5R for 3 months at 40°C, but the co-amorphous system with NaGC (AntiY5R-NaGC; 1:9 molar ratio) provided the highest improvement in AntiY5R dissolution, which was approximately 50 times greater than that of the crystals. Possible intermolecular interactions via the glycine moiety of NaGC more than the other bile salts would contribute to the highest dissolution enhancement with AntiY5R-NaGC. Thus, NaGC would be a promising co-former for formulating stable co-amorphous systems to enhance the dissolution behavior of brick dust molecules.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
8.80
自引率
4.10%
发文量
211
审稿时长
36 days
期刊介绍: The European Journal of Pharmaceutics and Biopharmaceutics provides a medium for the publication of novel, innovative and hypothesis-driven research from the areas of Pharmaceutics and Biopharmaceutics. Topics covered include for example: Design and development of drug delivery systems for pharmaceuticals and biopharmaceuticals (small molecules, proteins, nucleic acids) Aspects of manufacturing process design Biomedical aspects of drug product design Strategies and formulations for controlled drug transport across biological barriers Physicochemical aspects of drug product development Novel excipients for drug product design Drug delivery and controlled release systems for systemic and local applications Nanomaterials for therapeutic and diagnostic purposes Advanced therapy medicinal products Medical devices supporting a distinct pharmacological effect.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信